The global Hepatitis A immunoglobulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Hepatitis A immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Hepatitis A immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Hepatitis A immunoglobulin include CSL Behring, AIM Vaccine, Sinovac Biotech, Pukang Biotechnology, Zhifei Biological Products, Changchun Lnstitute Of Biological Products, Native Antigen, GSK and Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Hepatitis A immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A immunoglobulin.

Report Scope

The Hepatitis A immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis A immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hepatitis A immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hepatitis A immunoglobulin Market Report

Report Metric	Details
Report Name	Hepatitis A immunoglobulin Market
Segment by Type	Inactivated Attenuated
Segment by Application	Hospital Pharmacy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSL Behring, AIM Vaccine, Sinovac Biotech, Pukang Biotechnology, Zhifei Biological Products, Changchun Lnstitute Of Biological Products, Native Antigen, GSK, Merck, Sanofi, Dr. Reddy's Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis A immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis A immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hepatitis A immunoglobulin Market report?

Ans: The main players in the Hepatitis A immunoglobulin Market are CSL Behring, AIM Vaccine, Sinovac Biotech, Pukang Biotechnology, Zhifei Biological Products, Changchun Lnstitute Of Biological Products, Native Antigen, GSK, Merck, Sanofi, Dr. Reddy's Laboratories

What are the Application segmentation covered in the Hepatitis A immunoglobulin Market report?

Ans: The Applications covered in the Hepatitis A immunoglobulin Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Hepatitis A immunoglobulin Market report?

Ans: The Types covered in the Hepatitis A immunoglobulin Market report are Inactivated, Attenuated

1 Hepatitis A immunoglobulin Market Overview

1.1 Product Overview and Scope of Hepatitis A immunoglobulin

1.2 Hepatitis A immunoglobulin Segment by Type

1.2.1 Global Hepatitis A immunoglobulin Market Value Comparison by Type (2024-2030)

1.2.2 Inactivated

1.2.3 Attenuated

1.3 Hepatitis A immunoglobulin Segment by Application

1.3.1 Global Hepatitis A immunoglobulin Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Other

1.4 Global Hepatitis A immunoglobulin Market Size Estimates and Forecasts

1.4.1 Global Hepatitis A immunoglobulin Revenue 2019-2030

1.4.2 Global Hepatitis A immunoglobulin Sales 2019-2030

1.4.3 Global Hepatitis A immunoglobulin Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Hepatitis A immunoglobulin Market Competition by Manufacturers

2.1 Global Hepatitis A immunoglobulin Sales Market Share by Manufacturers (2019-2024)

2.2 Global Hepatitis A immunoglobulin Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Hepatitis A immunoglobulin Average Price by Manufacturers (2019-2024)

2.4 Global Hepatitis A immunoglobulin Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Hepatitis A immunoglobulin, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Hepatitis A immunoglobulin, Product Type & Application

2.7 Hepatitis A immunoglobulin Market Competitive Situation and Trends

2.7.1 Hepatitis A immunoglobulin Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Hepatitis A immunoglobulin Players Market Share by Revenue

2.7.3 Global Hepatitis A immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hepatitis A immunoglobulin Retrospective Market Scenario by Region

3.1 Global Hepatitis A immunoglobulin Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Hepatitis A immunoglobulin Global Hepatitis A immunoglobulin Sales by Region: 2019-2030

3.2.1 Global Hepatitis A immunoglobulin Sales by Region: 2019-2024

3.2.2 Global Hepatitis A immunoglobulin Sales by Region: 2025-2030

3.3 Global Hepatitis A immunoglobulin Global Hepatitis A immunoglobulin Revenue by Region: 2019-2030

3.3.1 Global Hepatitis A immunoglobulin Revenue by Region: 2019-2024

3.3.2 Global Hepatitis A immunoglobulin Revenue by Region: 2025-2030

3.4 North America Hepatitis A immunoglobulin Market Facts & Figures by Country

3.4.1 North America Hepatitis A immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Hepatitis A immunoglobulin Sales by Country (2019-2030)

3.4.3 North America Hepatitis A immunoglobulin Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Hepatitis A immunoglobulin Market Facts & Figures by Country

3.5.1 Europe Hepatitis A immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Hepatitis A immunoglobulin Sales by Country (2019-2030)

3.5.3 Europe Hepatitis A immunoglobulin Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Hepatitis A immunoglobulin Market Facts & Figures by Country

3.6.1 Asia Pacific Hepatitis A immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Hepatitis A immunoglobulin Sales by Country (2019-2030)

3.6.3 Asia Pacific Hepatitis A immunoglobulin Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Hepatitis A immunoglobulin Market Facts & Figures by Country

3.7.1 Latin America Hepatitis A immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Hepatitis A immunoglobulin Sales by Country (2019-2030)

3.7.3 Latin America Hepatitis A immunoglobulin Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Hepatitis A immunoglobulin Market Facts & Figures by Country

3.8.1 Middle East and Africa Hepatitis A immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Hepatitis A immunoglobulin Sales by Country (2019-2030)

3.8.3 Middle East and Africa Hepatitis A immunoglobulin Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Hepatitis A immunoglobulin Sales by Type (2019-2030)

4.1.1 Global Hepatitis A immunoglobulin Sales by Type (2019-2024)

4.1.2 Global Hepatitis A immunoglobulin Sales by Type (2025-2030)

4.1.3 Global Hepatitis A immunoglobulin Sales Market Share by Type (2019-2030)

4.2 Global Hepatitis A immunoglobulin Revenue by Type (2019-2030)

4.2.1 Global Hepatitis A immunoglobulin Revenue by Type (2019-2024)

4.2.2 Global Hepatitis A immunoglobulin Revenue by Type (2025-2030)

4.2.3 Global Hepatitis A immunoglobulin Revenue Market Share by Type (2019-2030)

4.3 Global Hepatitis A immunoglobulin Price by Type (2019-2030)

5 Segment by Application

5.1 Global Hepatitis A immunoglobulin Sales by Application (2019-2030)

5.1.1 Global Hepatitis A immunoglobulin Sales by Application (2019-2024)

5.1.2 Global Hepatitis A immunoglobulin Sales by Application (2025-2030)

5.1.3 Global Hepatitis A immunoglobulin Sales Market Share by Application (2019-2030)

5.2 Global Hepatitis A immunoglobulin Revenue by Application (2019-2030)

5.2.1 Global Hepatitis A immunoglobulin Revenue by Application (2019-2024)

5.2.2 Global Hepatitis A immunoglobulin Revenue by Application (2025-2030)

5.2.3 Global Hepatitis A immunoglobulin Revenue Market Share by Application (2019-2030)

5.3 Global Hepatitis A immunoglobulin Price by Application (2019-2030)

6 Key Companies Profiled

6.1 CSL Behring

6.1.1 CSL Behring Corporation Information

6.1.2 CSL Behring Description and Business Overview

6.1.3 CSL Behring Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2019-2024)

6.1.4 CSL Behring Hepatitis A immunoglobulin Product Portfolio

6.1.5 CSL Behring Recent Developments/Updates

6.2 AIM Vaccine

6.2.1 AIM Vaccine Corporation Information

6.2.2 AIM Vaccine Description and Business Overview

6.2.3 AIM Vaccine Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AIM Vaccine Hepatitis A immunoglobulin Product Portfolio

6.2.5 AIM Vaccine Recent Developments/Updates

6.3 Sinovac Biotech

6.3.1 Sinovac Biotech Corporation Information

6.3.2 Sinovac Biotech Description and Business Overview

6.3.3 Sinovac Biotech Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sinovac Biotech Hepatitis A immunoglobulin Product Portfolio

6.3.5 Sinovac Biotech Recent Developments/Updates

6.4 Pukang Biotechnology

6.4.1 Pukang Biotechnology Corporation Information

6.4.2 Pukang Biotechnology Description and Business Overview

6.4.3 Pukang Biotechnology Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pukang Biotechnology Hepatitis A immunoglobulin Product Portfolio

6.4.5 Pukang Biotechnology Recent Developments/Updates

6.5 Zhifei Biological Products

6.5.1 Zhifei Biological Products Corporation Information

6.5.2 Zhifei Biological Products Description and Business Overview

6.5.3 Zhifei Biological Products Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Zhifei Biological Products Hepatitis A immunoglobulin Product Portfolio

6.5.5 Zhifei Biological Products Recent Developments/Updates

6.6 Changchun Lnstitute Of Biological Products

6.6.1 Changchun Lnstitute Of Biological Products Corporation Information

6.6.2 Changchun Lnstitute Of Biological Products Description and Business Overview

6.6.3 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product Portfolio

6.6.5 Changchun Lnstitute Of Biological Products Recent Developments/Updates

6.7 Native Antigen

6.6.1 Native Antigen Corporation Information

6.6.2 Native Antigen Description and Business Overview

6.6.3 Native Antigen Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Native Antigen Hepatitis A immunoglobulin Product Portfolio

6.7.5 Native Antigen Recent Developments/Updates

6.8 GSK

6.8.1 GSK Corporation Information

6.8.2 GSK Description and Business Overview

6.8.3 GSK Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2019-2024)

6.8.4 GSK Hepatitis A immunoglobulin Product Portfolio

6.8.5 GSK Recent Developments/Updates

6.9 Merck

6.9.1 Merck Corporation Information

6.9.2 Merck Description and Business Overview

6.9.3 Merck Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Merck Hepatitis A immunoglobulin Product Portfolio

6.9.5 Merck Recent Developments/Updates

6.10 Sanofi

6.10.1 Sanofi Corporation Information

6.10.2 Sanofi Description and Business Overview

6.10.3 Sanofi Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Sanofi Hepatitis A immunoglobulin Product Portfolio

6.10.5 Sanofi Recent Developments/Updates

6.11 Dr. Reddy's Laboratories

6.11.1 Dr. Reddy's Laboratories Corporation Information

6.11.2 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Description and Business Overview

6.11.3 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product Portfolio

6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Hepatitis A immunoglobulin Industry Chain Analysis

7.2 Hepatitis A immunoglobulin Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Hepatitis A immunoglobulin Production Mode & Process

7.4 Hepatitis A immunoglobulin Sales and Marketing

7.4.1 Hepatitis A immunoglobulin Sales Channels

7.4.2 Hepatitis A immunoglobulin Distributors

7.5 Hepatitis A immunoglobulin Customers

8 Hepatitis A immunoglobulin Market Dynamics

8.1 Hepatitis A immunoglobulin Industry Trends

8.2 Hepatitis A immunoglobulin Market Drivers

8.3 Hepatitis A immunoglobulin Market Challenges

8.4 Hepatitis A immunoglobulin Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

SINOVAC BIOTECH

GSK

Sanofi

Dr. Reddy’s Laboratories

AIM Vaccine

Pukang Biotechnology

Zhifei Biological Products

Changchun Lnstitute Of Biological Products

Native Antigen

List of Tables

Table 1. Global Hepatitis A immunoglobulin Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Hepatitis A immunoglobulin Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Hepatitis A immunoglobulin Market Competitive Situation by Manufacturers in 2023

Table 4. Global Hepatitis A immunoglobulin Sales (Doses) of Key Manufacturers (2019-2024)

Table 5. Global Hepatitis A immunoglobulin Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Hepatitis A immunoglobulin Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Hepatitis A immunoglobulin Average Price (US$/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Hepatitis A immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Hepatitis A immunoglobulin, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Hepatitis A immunoglobulin, Product Type & Application

Table 12. Global Key Manufacturers of Hepatitis A immunoglobulin, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Hepatitis A immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A immunoglobulin as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Hepatitis A immunoglobulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Hepatitis A immunoglobulin Sales by Region (2019-2024) & (Doses)

Table 18. Global Hepatitis A immunoglobulin Sales Market Share by Region (2019-2024)

Table 19. Global Hepatitis A immunoglobulin Sales by Region (2025-2030) & (Doses)

Table 20. Global Hepatitis A immunoglobulin Sales Market Share by Region (2025-2030)

Table 21. Global Hepatitis A immunoglobulin Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Hepatitis A immunoglobulin Revenue Market Share by Region (2019-2024)

Table 23. Global Hepatitis A immunoglobulin Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Hepatitis A immunoglobulin Revenue Market Share by Region (2025-2030)

Table 25. North America Hepatitis A immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Hepatitis A immunoglobulin Sales by Country (2019-2024) & (Doses)

Table 27. North America Hepatitis A immunoglobulin Sales by Country (2025-2030) & (Doses)

Table 28. North America Hepatitis A immunoglobulin Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Hepatitis A immunoglobulin Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Hepatitis A immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Hepatitis A immunoglobulin Sales by Country (2019-2024) & (Doses)

Table 32. Europe Hepatitis A immunoglobulin Sales by Country (2025-2030) & (Doses)

Table 33. Europe Hepatitis A immunoglobulin Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Hepatitis A immunoglobulin Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Hepatitis A immunoglobulin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Hepatitis A immunoglobulin Sales by Region (2019-2024) & (Doses)

Table 37. Asia Pacific Hepatitis A immunoglobulin Sales by Region (2025-2030) & (Doses)

Table 38. Asia Pacific Hepatitis A immunoglobulin Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Hepatitis A immunoglobulin Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Hepatitis A immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Hepatitis A immunoglobulin Sales by Country (2019-2024) & (Doses)

Table 42. Latin America Hepatitis A immunoglobulin Sales by Country (2025-2030) & (Doses)

Table 43. Latin America Hepatitis A immunoglobulin Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Hepatitis A immunoglobulin Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Hepatitis A immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Hepatitis A immunoglobulin Sales by Country (2019-2024) & (Doses)

Table 47. Middle East & Africa Hepatitis A immunoglobulin Sales by Country (2025-2030) & (Doses)

Table 48. Middle East & Africa Hepatitis A immunoglobulin Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Hepatitis A immunoglobulin Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Hepatitis A immunoglobulin Sales (Doses) by Type (2019-2024)

Table 51. Global Hepatitis A immunoglobulin Sales (Doses) by Type (2025-2030)

Table 52. Global Hepatitis A immunoglobulin Sales Market Share by Type (2019-2024)

Table 53. Global Hepatitis A immunoglobulin Sales Market Share by Type (2025-2030)

Table 54. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Hepatitis A immunoglobulin Revenue Market Share by Type (2019-2024)

Table 57. Global Hepatitis A immunoglobulin Revenue Market Share by Type (2025-2030)

Table 58. Global Hepatitis A immunoglobulin Price (US$/Dose) by Type (2019-2024)

Table 59. Global Hepatitis A immunoglobulin Price (US$/Dose) by Type (2025-2030)

Table 60. Global Hepatitis A immunoglobulin Sales (Doses) by Application (2019-2024)

Table 61. Global Hepatitis A immunoglobulin Sales (Doses) by Application (2025-2030)

Table 62. Global Hepatitis A immunoglobulin Sales Market Share by Application (2019-2024)

Table 63. Global Hepatitis A immunoglobulin Sales Market Share by Application (2025-2030)

Table 64. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Hepatitis A immunoglobulin Revenue Market Share by Application (2019-2024)

Table 67. Global Hepatitis A immunoglobulin Revenue Market Share by Application (2025-2030)

Table 68. Global Hepatitis A immunoglobulin Price (US$/Dose) by Application (2019-2024)

Table 69. Global Hepatitis A immunoglobulin Price (US$/Dose) by Application (2025-2030)

Table 70. CSL Behring Corporation Information

Table 71. CSL Behring Description and Business Overview

Table 72. CSL Behring Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 73. CSL Behring Hepatitis A immunoglobulin Product

Table 74. CSL Behring Recent Developments/Updates

Table 75. AIM Vaccine Corporation Information

Table 76. AIM Vaccine Description and Business Overview

Table 77. AIM Vaccine Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 78. AIM Vaccine Hepatitis A immunoglobulin Product

Table 79. AIM Vaccine Recent Developments/Updates

Table 80. Sinovac Biotech Corporation Information

Table 81. Sinovac Biotech Description and Business Overview

Table 82. Sinovac Biotech Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 83. Sinovac Biotech Hepatitis A immunoglobulin Product

Table 84. Sinovac Biotech Recent Developments/Updates

Table 85. Pukang Biotechnology Corporation Information

Table 86. Pukang Biotechnology Description and Business Overview

Table 87. Pukang Biotechnology Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 88. Pukang Biotechnology Hepatitis A immunoglobulin Product

Table 89. Pukang Biotechnology Recent Developments/Updates

Table 90. Zhifei Biological Products Corporation Information

Table 91. Zhifei Biological Products Description and Business Overview

Table 92. Zhifei Biological Products Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 93. Zhifei Biological Products Hepatitis A immunoglobulin Product

Table 94. Zhifei Biological Products Recent Developments/Updates

Table 95. Changchun Lnstitute Of Biological Products Corporation Information

Table 96. Changchun Lnstitute Of Biological Products Description and Business Overview

Table 97. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 98. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product

Table 99. Changchun Lnstitute Of Biological Products Recent Developments/Updates

Table 100. Native Antigen Corporation Information

Table 101. Native Antigen Description and Business Overview

Table 102. Native Antigen Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 103. Native Antigen Hepatitis A immunoglobulin Product

Table 104. Native Antigen Recent Developments/Updates

Table 105. GSK Corporation Information

Table 106. GSK Description and Business Overview

Table 107. GSK Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 108. GSK Hepatitis A immunoglobulin Product

Table 109. GSK Recent Developments/Updates

Table 110. Merck Corporation Information

Table 111. Merck Description and Business Overview

Table 112. Merck Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 113. Merck Hepatitis A immunoglobulin Product

Table 114. Merck Recent Developments/Updates

Table 115. Sanofi Corporation Information

Table 116. Sanofi Description and Business Overview

Table 117. Sanofi Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 118. Sanofi Hepatitis A immunoglobulin Product

Table 119. Sanofi Recent Developments/Updates

Table 120. Dr. Reddy's Laboratories Corporation Information

Table 121. Dr. Reddy's Laboratories Description and Business Overview

Table 122. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 123. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product

Table 124. Dr. Reddy's Laboratories Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Hepatitis A immunoglobulin Distributors List

Table 128. Hepatitis A immunoglobulin Customers List

Table 129. Hepatitis A immunoglobulin Market Trends

Table 130. Hepatitis A immunoglobulin Market Drivers

Table 131. Hepatitis A immunoglobulin Market Challenges

Table 132. Hepatitis A immunoglobulin Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Hepatitis A immunoglobulin

Figure 2. Global Hepatitis A immunoglobulin Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Hepatitis A immunoglobulin Market Share by Type in 2023 & 2030

Figure 4. Inactivated Product Picture

Figure 5. Attenuated Product Picture

Figure 6. Global Hepatitis A immunoglobulin Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Hepatitis A immunoglobulin Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Pharmacy

Figure 10. Other

Figure 11. Global Hepatitis A immunoglobulin Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Hepatitis A immunoglobulin Market Size (2019-2030) & (US$ Million)

Figure 13. Global Hepatitis A immunoglobulin Sales (2019-2030) & (Doses)

Figure 14. Global Hepatitis A immunoglobulin Average Price (US$/Dose) & (2019-2030)

Figure 15. Hepatitis A immunoglobulin Report Years Considered

Figure 16. Hepatitis A immunoglobulin Sales Share by Manufacturers in 2023

Figure 17. Global Hepatitis A immunoglobulin Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Hepatitis A immunoglobulin Players: Market Share by Revenue in 2023

Figure 19. Hepatitis A immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Hepatitis A immunoglobulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Hepatitis A immunoglobulin Sales Market Share by Country (2019-2030)

Figure 22. North America Hepatitis A immunoglobulin Revenue Market Share by Country (2019-2030)

Figure 23. United States Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Hepatitis A immunoglobulin Sales Market Share by Country (2019-2030)

Figure 26. Europe Hepatitis A immunoglobulin Revenue Market Share by Country (2019-2030)

Figure 27. Germany Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Hepatitis A immunoglobulin Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Hepatitis A immunoglobulin Revenue Market Share by Region (2019-2030)

Figure 34. China Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Hepatitis A immunoglobulin Sales Market Share by Country (2019-2030)

Figure 42. Latin America Hepatitis A immunoglobulin Revenue Market Share by Country (2019-2030)

Figure 43. Mexico Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Hepatitis A immunoglobulin Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Hepatitis A immunoglobulin Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Hepatitis A immunoglobulin by Type (2019-2030)

Figure 52. Global Revenue Market Share of Hepatitis A immunoglobulin by Type (2019-2030)

Figure 53. Global Hepatitis A immunoglobulin Price (US$/Dose) by Type (2019-2030)

Figure 54. Global Sales Market Share of Hepatitis A immunoglobulin by Application (2019-2030)

Figure 55. Global Revenue Market Share of Hepatitis A immunoglobulin by Application (2019-2030)

Figure 56. Global Hepatitis A immunoglobulin Price (US$/Dose) by Application (2019-2030)

Figure 57. Hepatitis A immunoglobulin Value Chain

Figure 58. Hepatitis A immunoglobulin Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Self-destructing Vaccine Syringes Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34F14139

Mon Aug 26 00:00:00 UTC 2024

Add to Cart

Global Adeno-Associated Virus Vectors in Gene Therapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34W12809

Mon Aug 26 00:00:00 UTC 2024

Add to Cart

Global Sterile Self-Disable Vaccine Syringes Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24A14215

Mon Aug 26 00:00:00 UTC 2024

Add to Cart

Global Legionella Routine Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-22D11845

Sun Aug 25 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions